Monitoring the Efficacy of Adoptively Transferred Prostate Cancer–Targeted Human T Lymphocytes with PET and Bioluminescence Imaging
暂无分享,去创建一个
Michel Sadelain | Vladimir Ponomarev | Hedvig Hricak | H. Hricak | M. Sadelain | Gertrude Gunset | V. Ponomarev | N. Pillarsetty | S. Cai | M. Olszewska | Malgorzata Olszewska | Nagavarakishore Pillarsetty | Shangde Cai | Gertrude Gunset | Konstantin Dobrenkov | Yury Likar | Larissa Shenker | K. Dobrenkov | Yury Likar | L. Shenker
[1] Z. Eshhar,et al. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[2] S. Rosenberg,et al. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain , 1993, The Journal of experimental medicine.
[3] R. Blasberg,et al. Imaging the expression of transfected genes in vivo. , 1995, Cancer research.
[4] J. Trapani,et al. Expression in cytotoxic T lymphocytes of a single‐chain anti‐carcinoembryonic antigen antibody. Redirected Fas ligand‐mediated lysis of colon carcinoma , 1998, European journal of immunology.
[5] V. Diehl,et al. An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30. , 1998, Cancer research.
[6] V. Diehl,et al. A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA , 1998, Gene Therapy.
[7] P. Hand,et al. Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor. , 1999, Human gene therapy.
[8] N. Bander,et al. Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen. , 1999, Neoplasia.
[9] Daniel E. Hall,et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. , 2000, Neoplasia.
[10] B. Seliger,et al. Tumor-Specific T Cell Activation by Recombinant Immunoreceptors: CD3ζ Signaling and CD28 Costimulation Are Simultaneously Required for Efficient IL-2 Secretion and Can Be Integrated Into One Combined CD28/CD3ζ Signaling Receptor Molecule1 , 2001, The Journal of Immunology.
[11] S. Forman,et al. T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. , 2003, Blood.
[12] Michel Sadelain,et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes , 2003, Nature Biotechnology.
[13] R. Blasberg,et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[14] R. Blasberg,et al. Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging. , 2003, Neoplasia.
[15] S. Larson,et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 , 2003, Nature Medicine.
[16] Sanjiv S Gambhir,et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] Michel Sadelain,et al. Targeting tumours with genetically enhanced T lymphocytes , 2003, Nature Reviews Cancer.
[18] S. Forman,et al. Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T Cells , 2004, Cancer Research.
[19] E. Pamer,et al. In vitro Stimulation with WT1 Peptide-Loaded Epstein-Barr Virus-Positive B Cells Elicits High Frequencies of WT1 Peptide-Specific T Cells with In vitro and In vivo Tumoricidal Activity , 2004, Clinical Cancer Research.
[20] Vladimir Ponomarev,et al. Molecular Imaging of Temporal Dynamics and Spatial Heterogeneity of Hypoxia-Inducible Factor-1 Signal Transduction Activity in Tumors in Living Mice , 2004, Cancer Research.
[21] Sanjiv S Gambhir,et al. Multimodality imaging of lymphocytic migration using lentiviral-based transduction of a tri-fusion reporter gene. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[22] Michel Sadelain,et al. Targeted elimination of prostate cancer by genetically directed human T lymphocytes. , 2005, Cancer research.
[23] J. Wolchok,et al. Induction of autoantibodies to syngeneic prostate‐specific membrane antigen by xenogeneic vaccination , 2005, International journal of cancer.
[24] S. Rosenberg,et al. Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. , 2005, Human gene therapy.
[25] H. Heslop,et al. Current status of genetic modification of T cells for cancer treatment. , 2005, Cytotherapy.
[26] Sanjiv S Gambhir,et al. Visualization of a primary anti-tumor immune response by positron emission tomography. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] S. Larson,et al. [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[28] S. Gambhir,et al. Monitoring the Antitumor Response of Naive and Memory CD8 T Cells in RAG1−/− Mice by Positron-Emission Tomography1 , 2006, The Journal of Immunology.
[29] H. Heslop,et al. T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells. , 2006, Blood.
[30] David D. Smith,et al. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. , 2006, Cancer research.
[31] S. Rosenberg,et al. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.
[32] S. Larson,et al. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[33] J. Sprent,et al. Cytokines and T-cell homeostasis. , 2003, Current opinion in immunology.
[34] V. Ponomarev,et al. A Human-Derived Reporter Gene for Noninvasive Imaging in Humans: Mitochondrial Thymidine Kinase Type 2 , 2007, Journal of Nuclear Medicine.